Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
dc.contributor.author | Opperman, Jacobus B.![]() |
|
dc.contributor.author | Tshifularo, Mashudu![]() |
|
dc.date.accessioned | 2023-08-16T08:08:35Z | |
dc.date.available | 2023-08-16T08:08:35Z | |
dc.date.issued | 2022-10 | |
dc.description.abstract | INTRODUCTION : Post-adenotonsillectomy pain is often severe, requiring substantial analgesia in the first 48–72 h. This pain is not only distressing to the patient and his or her parents, but often reflects poorly on an otherwise well performed procedure. Safe, simple and effective post-adenotonsillectomy pain control is still clinically elusive, even though a multitude of surgical and analgesic interventions have been proposed. OBJECTIVES : To investigate the analgesic properties of immediate post-operative application of xylocaine 10% pump spray to the tonsillar fossae in children having undergone adenotonsillectomy and how this impacts on anesthetic emergence and pain control in the first 24-h. METHODS : In this double-blinded, randomized, placebo-controlled trial, 80 children were stratified into two groups: Group I (3-8 years-old) and Group II (9–14 years-old). Within these groups, participants were randomized to receive either xylocaine 10% pump spray or normal saline 0.9% post-operatively. A standardized anesthetic/analgesic regime was used intra-operatively. The same surgeon performed all surgeries using bi-polar diathermy. Outcome variables included state of anesthetic emergence; pain scores at specific intervals; need for rescue analgesia; post-operative nausea and vomiting; time to first oral intake and comfort associated with initial oral intake. RESULTS : Xylocaine 10% pump spray consistently provided superior pain control at all time intervals compared to normal saline 0.9% (p = 0.011). This was most pronounced in children 3–8 years old (Group I). Xylocaine 10% pump spray and normal saline 0.9% provided similar pain relief in children 9–14 years old (Group (II) (p = 0.640). Children receiving xylocaine had a decreased incidence of emergence delirium and consistently required less rescue analgesia (p = 0.005). Children who received xylocaine did not eat sooner post-operatively, but they experienced less pain when ingesting liquids (p = 0.003) and solids (p = 0.000). Children who received xylocaine did not experience increased post-operative complications (p = 1.000) or nausea and vomiting (p = 0.153). CONCLUSION : Xylocaine 10% spray may serve as a valuable adjunct to effective pain control post-adenotonsillectomy, especially if long acting opioids are contraindicated, as with patients with obstructive sleep apnea. The benefit of xylocaine appears to be negligible when a long acting opioid is administered. The benefits of xylocaine were most noteworthy in children aged 3–8 years old. This is the largest trial (n = 80) to date to assess the efficacy of xylocaine spray in isolation post-adenotonsillectomy. Xylocaine also offers improved comfort with oral intake and decreases emergence delirium and need for rescue analgesia without any increase in post-operative complications. Local anesthesia may decrease costs and help to solve the conundrum of a painless adenotonsillectomy especially in resource-limited settings. | en_US |
dc.description.department | Otorhinolaryngology | en_US |
dc.description.librarian | hj2023 | en_US |
dc.description.uri | https://www.elsevier.com/locate/ijporl | en_US |
dc.identifier.citation | Opperman, J.B. & Tshifularo, M.I. 2022, 'The application of xylocaine 10% pump-spray to improve immediate post-adenotonsillectomy pain in children : a randomized controlled trial', International Journal of Pediatric Otorhinolaryngology, vol. 161, art. 111260, pp. 1-7, doi : 10.1016/j.ijporl.2022.111260. | en_US |
dc.identifier.issn | 0165-5876 (print) | |
dc.identifier.issn | 1872-8464 (online) | |
dc.identifier.other | 10.1016/j.ijporl.2022.111260 | |
dc.identifier.uri | http://hdl.handle.net/2263/91936 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | © 2022 Elsevier B.V. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in International Journal of Pediatric Otorhinolaryngology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in International Journal of Pediatric Otorhinolaryngology, vol. 161, art. 111260, pp. 1-7, doi : 10.1016/j.ijporl.2022.111260. | en_US |
dc.subject | Adenotonsillectomy | en_US |
dc.subject | Tonsillectomy | en_US |
dc.subject | Pain | en_US |
dc.subject | Children | en_US |
dc.subject | Local anesthetic | en_US |
dc.subject | Xylocaine | en_US |
dc.subject | Emergence delirium | en_US |
dc.subject | Lidocaine | en_US |
dc.subject | Lignocaine | en_US |
dc.subject | SDG-03: Good health and well-being | en_US |
dc.title | The application of xylocaine 10% pump-spray to improve immediate post-adenotonsillectomy pain in children : a randomized controlled trial | en_US |
dc.type | Postprint Article | en_US |